Barclays Starts Retrophin (RTRX) at Overweight

April 22, 2019 12:42 AM EDT Send to a Friend
Barclays analyst Geoff Meacham initiates coverage on Retrophin (NASDAQ: RTRX) with a Overweight rating and a price target of $36.00.The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login